[1]Patent:WO2014/153055,2014,A2.Locationinpatent:Paragraph0112-0113
[2]Patent:WO2010/17048,2010,A1.Locationinpatent:Page/Pagecolumn33
[1]CurrentPatentAssignee:XIOSTHERAPEUTICS-WO2020/106625,2020,A1Locationinpatent:Page/Pagecolumn60
501130-49-0
943751-93-7
24331-94-0
6798-05-6
943749-57-3
1392491-58-5
1432792-62-5 | 2-[(1H-1,2,3-triazol-1-yl)methyl]piperidine | AA00NQZK | MFCD27920171
2246616-92-0 | {3-methyl-4-[(methylcarbamoyl)amino]phenyl}boronic acid | AA00RO2J | MFCD32206340
890014-18-3 | N-(6-Methylthieno[2,3-d]pyrimidin-4-yl)glycine | AA00VRW9 | MFCD06255217
352666-89-8 | 3-(2-Methyl-3-oxo-2,3-dihydro-4h-1,4-benzoxazin-4-yl)propanoic acid | AA00VT5I | MFCD01834178
29147-96-4 | 4-ethylbenzene-1-carboximidamide hydrochloride | AA00VUIH | MFCD19381940
1210893-58-5 | (4-(4-Chlorophenyl)tetrahydro-2H-pyran-4-yl)methanamine hydrochloride | AA00VWNQ | MFCD11043049
52603-58-4 | N-(2-Amino-benzothiazol-6-yl)-benzamide | AA016K94 | MFCD00608286
522604-25-7 | 2-Chloroimidazo[1,2-a]pyridine-3-carboxylic acid | AA018FLF | MFCD03482885
869294-22-4 | (2-ethoxypyridin-4-yl)methanamine | AA018H2S | MFCD09730775
1015946-14-1 | 1-(Benzo[d]oxazol-2-yl)piperidin-4-ol | AA018NJX | MFCD10414187
